These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 606993)

  • 21. [Sodium and potassium levels in the blood serum and urine of patients with chronic diffuse liver disease].
    Vasil'eva LN
    Ter Arkh; 1966 Jan; 38(1):55-9. PubMed ID: 5982215
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gas chromatographic analysis of lipid fatty acids in liver biopsies in chronic diffuse liver diseases].
    Bliudzin IuA; Mokhov VM
    Lab Delo; 1983; (7):30-3. PubMed ID: 6194351
    [No Abstract]   [Full Text] [Related]  

  • 23. [State of free amino acid metabolism in children with chronic liver diseases].
    Popov DT
    Vopr Okhr Materin Det; 1976 Sep; 21(9):44-5. PubMed ID: 997392
    [No Abstract]   [Full Text] [Related]  

  • 24. Kinetic analysis of thyroxine outside thyroid with 131-I-tyroxine by aid of computer--with special reference to liver diseases.
    Yumoto Y; Namba T; Yamamoto H
    Acta Med Okayama (1952); 1970 Aug; 24(4):457-70. PubMed ID: 4254200
    [No Abstract]   [Full Text] [Related]  

  • 25. [Disorders of carbohydrate metabolism in chronic hepatitis and cirrhosis of the liver (author's transl)].
    Danko M; Spanár E; Holan J; Záhradný V; Kurocka J
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):173-7. PubMed ID: 4447982
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of iron metabolism in cases of hepatitis and liver cirrhosis.
    Stojcevski T; Grunevska B; Davcev P; Marković V
    Acta Med Iugosl; 1970; 24(1):41-8. PubMed ID: 5455213
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease.
    Suou T; Yamada S; Hosho K; Yoshikawa N; Kawasaki H
    Hepatology; 1996 May; 23(5):1154-8. PubMed ID: 8621148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phenazon metabolism in children with liver diseases].
    Orzechowska-Juzwenko K; Rabenda C; Wiela-Hojeńska A; Kubicz Z; Saraczyńska E; Rudkowski Z; Drabik E
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):265-7. PubMed ID: 1437728
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vitamin B 12 absorption in chronic liver diseases].
    Bondar' ZA; Danchenko AG; Zolotnitskaia RP
    Sov Med; 1976; (5):87-90. PubMed ID: 968620
    [No Abstract]   [Full Text] [Related]  

  • 30. Activity of chronic hepatitis. Correlation of clinical, biochemical and histological parameters in 32 cases.
    Gayotto LC; Strauss E; Alves VA; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):288-93. PubMed ID: 6200913
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and experimental studies on collagen metabolism in hepatic disorders.
    Kucharz E
    Med Interne; 1984; 22(2):129-40. PubMed ID: 6330869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of tests for estimation of disease activity in patients with chronic hepatitis and liver cirrhosis].
    Kurdybaĭlo FV; Iakhontova OI; Orlova IN
    Vrach Delo; 1976 Dec; (12):68-71. PubMed ID: 1014592
    [No Abstract]   [Full Text] [Related]  

  • 33. The metabolism of vitamin B-12 in chronic hepatitis and cirrhosis studied with the aid of radiocobalamine.
    Spîrchez T; Gheorghescu B; Jovin G; Merculiev E
    Rom Med Rev; 1968; 12(2):18-24. PubMed ID: 5655991
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of acute and chronic liver disease on sulfate metabolism in man.
    Galambos JT
    Am J Gastroenterol; 1967 Feb; 47(2):105-12. PubMed ID: 4225376
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathogenesis of disorder of glucose tolerance and diabetes mellitus in patients with chronic hepatitis and liver cirrhosis].
    Moskvichev AM; Shlimovich PB
    Sov Med; 1975 Sep; (9):110-4. PubMed ID: 1231013
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemical study of the bile in chronic hepatitis and liver cirrhosis].
    Ivanov AI; Radchenko VG
    Ter Arkh; 1977; 49(2):60-4. PubMed ID: 860232
    [No Abstract]   [Full Text] [Related]  

  • 37. [Osteopathies and calcium absorption in chronic liver diseases].
    Gossmann HH; Schaumlöffel E; Miller B; Martini GA
    Z Gastroenterol; 1975 Oct; 13(6):594-8. PubMed ID: 1224754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on the metabolism of prophyrins in chronic hepatitis and hepatic cirrhosis].
    Kleistein I; Casetti M; Kleinstein A; Ababei V; Strat M
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(1):67-72. PubMed ID: 5799872
    [No Abstract]   [Full Text] [Related]  

  • 40. Electron microscopic observations on chronic aggressive hepatitis: participation of hepatocytes in liver fibrosis.
    Groniowski J; Walski M
    Pathol Eur; 1975; 10(1):37-50. PubMed ID: 1178227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.